Leading expert in cancer prevention and screening, Dr. Nadir Arber, MD, shares insights on effective cancer prevention strategies and early detection methods. Dr. Arber, a Professor of Medicine and Gastroenterology at Tel Aviv University, heads the Integrated Cancer Prevention Center at Tel Aviv Sourasky Medical Center. His extensive background includes a focus on gastrointestinal cancers, with significant contributions to the development of molecular markers and innovative screening techniques. Dr. Arber's work in cancer gene therapy and his leadership in the Israeli Society of Gastroenterology highlight his commitment to advancing cancer care.
Plus de Cancer Prevention
Plus de Diagnostic Detectives Network
Effective Strategies for Cancer Prevention and Early Detection
Jump To Section
- Cancer Prevention Expertise
- Academic and Professional Background
- Gastrointestinal Cancer Focus
- Innovations in Cancer Screening
- Contributions to Cancer Gene Therapy
- Leadership and Publications
- Full Transcript
Cancer Prevention Expertise
Dr. Nadir Arber, MD, is renowned for his expertise in cancer prevention and early detection. As the head of the Integrated Cancer Prevention Center at Tel Aviv Sourasky Medical Center, he focuses on strategies to prevent cancer and detect it at an early stage. His work emphasizes the importance of screening and prevention in reducing cancer incidence and improving patient outcomes.
Academic and Professional Background
Dr. Arber's academic journey began at Hadassah Medical School in Jerusalem, where he earned his MD. He furthered his education with a Master of Science from Tel Aviv University and an MBA from the Reckanti School of Business Administration. His residency in internal medicine was completed at Rabin Medical Center, followed by a fellowship in gastroenterology at Tel Aviv Medical Center. Dr. Arber also completed a research fellowship at Columbia University's Comprehensive Cancer Center in New York.
Gastrointestinal Cancer Focus
Dr. Arber's clinical and research interests are centered on gastrointestinal cancers, including esophageal, pancreatic, and colorectal cancer. Since 1999, he has led the Gastrointestinal Oncology Unit at Tel Aviv Medical Center. His work involves developing new molecular markers for these cancers, aiming to enhance early detection and treatment options.
Innovations in Cancer Screening
Dr. Arber is at the forefront of developing novel screening methods for colorectal cancer. His research includes creating devices that can navigate the intestines to detect cancer early. These innovations are crucial for improving screening accuracy and patient compliance, ultimately leading to better cancer outcomes.
Contributions to Cancer Gene Therapy
Dr. Arber is actively involved in advancing cancer gene therapy, particularly for gastrointestinal cancers like pancreatic and colorectal cancer. His research aims to harness genetic insights to develop targeted therapies that can improve treatment efficacy and patient survival rates.
Leadership and Publications
In 2014, Dr. Arber was elected President of the Israeli Society of Gastroenterology, reflecting his leadership in the field. He has authored nearly 400 peer-reviewed publications and frequently presents at international conferences, sharing his insights on cancer prevention, screening, and treatment. His contributions continue to shape the future of cancer care.
Full Transcript
Dr. Anton Titov, MD: Hello from Tel Aviv! We are with Dr. Nadir Arber, MD, who is a Professor of Medicine and Gastroenterology at Tel Aviv University and Head of the Integrated Cancer Prevention Center at Tel Aviv Sourasky Medical Center. Dr. Arber obtained his MD from the Medical School at Hadassah, Jerusalem. He completed his Master of Science at Tel Aviv University and an MBA from the Recanati School of Business Administration.
Dr. Arber did his residency in internal medicine at Rabin Medical Center and a fellowship in gastroenterology at Tel Aviv Medical Center. He also completed a research fellowship at the Comprehensive Cancer Center at Columbia University in New York. In 1999, Dr. Nadir Arber became the head of the Gastrointestinal Oncology Unit at the Department of Gastroenterology at Tel Aviv Medical Center.
In 2002, Dr. Arber established the Integrated Cancer Prevention Center at Tel Aviv Medical Center. In 2014, he was chosen as the President of the Israeli Society of Gastroenterology. Dr. Arber's clinical and research interests include the prevention, screening, diagnosis, and treatment of gastrointestinal cancers, including esophageal, pancreatic, and colorectal cancer.
He leads the development of new molecular markers for gastrointestinal cancers and develops novel ways to screen for colorectal cancer with devices that can pass through the intestines. Dr. Arber is actively involved in the development of cancer gene therapy for gastrointestinal cancers, including pancreatic and colorectal cancer.
Dr. Arber has authored and co-authored almost 400 peer-reviewed publications in international medical journals and has presented numerous talks on cancer prevention, screening, and treatment at international conferences. Dr. Arber, hello and welcome!